Photo of Theodoros Kontoulis taken from klinikiagiosloukas.gr
Sep 23, 2024, 09:00
Theodoros Kontoulis: Heterogeneity of residual disease (RD) after NACT in breast cancer
Theodoros Kontoulis shared on LinkedIn:
“Most viewed in the last 7 days from JAMA Oncology: This Review analyzes the heterogeneity of residual disease (RD) after NACT in breast cancer.
Uncovering the anatomic and biological intricacies of RD will allow for increased precision in postneoadjuvant treatments, moving beyond the binary paradigm of RD vs pCR, toward more tailored adjuvant therapies.”
Source: Theodoros Kontoulis/LinkedIn
Theodoros Kontoulis is a Consultant Oncoplastic Breast Surgeon at Genesis Obstetrics Gynecology Surgery Hospital and St. Luke’s Hospital Thessaloniki. Previously, he was a Locum Consultant Breast Surgeon at Guy’s and St Thomas’ NHS Foundation Trust.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 09:31
Nov 14, 2024, 09:26
Nov 14, 2024, 09:21
Nov 14, 2024, 09:15
Nov 14, 2024, 00:19